Opdivo® (nivolumab) is registered for therapy of a cancer of a stomach

Show original
Company Bristol-Myers Squibb registered to Russian Federation the new indication for the immunooncological preparation Opdivo® (nivolumab).soglasno the updated instruction on application the preparation Opdivo® (nivolumab) Company Bristol-Myers Squibb registered to Russian Federation the new indication for the immunooncological preparation Opdivo® (nivolumab).soglasno the updated instruction on application the preparation Opdivo® (nivolumab)...

Full article is available at its source

Go to full article
Open the Connections Tree and see if FEDERAL STATE-FINANCED INSTITUTION... and are connected in any way
Try it

Sign up for more features!

Get full access to news analytics for free and without ads.